98%
921
2 minutes
20
Prompt and targeted antifungal treatment has a positive impact on the clinical outcome of mucormycosis; however, current diagnostic tools used in histopathology laboratories often fail to provide rapid results. Rapid culture-based strategies for early diagnosis of infections, which may influence treatment decisions, are urgently needed. Herein, we evaluated a microculture assay for the early diagnosis of mucormycosis in an immunocompetent murine model of disseminated infection, by comparing it with traditional diagnostic methods. The assay specificity was assessed using blood ( = 90) and tissue ( = 90) specimens obtained from mice infected with using different inoculum sizes [1 × 10, 1 × 10, and 1 × 10 colony forming units (CFUs)/mouse] and blood ( = 15) and tissue specimens ( = 15) from uninfected mice. Surprisingly, 26 of 90 (28.9%) blood samples revealed positive results by microculture, whereas all blood samples were negative when assayed by conventional culture. The overall positive conventional culture rate for the mouse tissue (kidney) samples was 31.1% (28/90). The calculated sensitivity for kidney microculture was 98.8% [95% confidence interval (CI) 96.6-100], with an assay specificity of 100%. Hence, the microculture assay may be useful for rapid culturing and diagnosis of mucormycosis caused by directly in blood and tissue samples. Hence, this method may allow for the timely administration of an appropriate treatment.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099612 | PMC |
http://dx.doi.org/10.3389/fmicb.2020.00440 | DOI Listing |
J Surg Case Rep
September 2025
Section of Histopathology, Department of Pathology and Laboratory Medicine, Aga Khan University Hospital, National Stadium Road, Karachi, 74800, Pakistan.
Cutaneous mucormycosis is a rare disease, which commonly affects immunocompromised individuals. It is highly invasive with devastating outcomes. Prompt actions such as surgical debridement and early initiation of antifungals are necessary to prevent the infection's rapid progression.
View Article and Find Full Text PDFPLoS One
September 2025
Chilean Invasive Mycosis Network, Santiago, Chile.
Background: Invasive mold diseases (IMDs) are a severe complication of immunocompromised subjects and an emerging problem among severely ill, apparently immunocompetent patients. The aim of this study was to describe the epidemiological and clinical features of IMDs in Chile.
Methods: Prospective study of IMD cases in children and adults from 11 reference hospitals in Chile from May 2019 to May 2021.
Am J Case Rep
September 2025
Department of Medicine, Infectious Disease Section, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
BACKGROUND Gastrointestinal mucormycosis is an underrecognized and underreported fungal infection with a high mortality rate. Diagnosis is often confounded by a non-specific constellation of signs and symptoms. We present a case of neutropenic colitis and ileocecal perforation secondary to gastrointestinal mucormycosis.
View Article and Find Full Text PDFMycoses
September 2025
Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Background: Mucormycosis is a rare, rapidly progressive fungal infection with a high mortality rate. However, clinical data of mucormycosis patients, especially those related to adverse outcomes in China, remain limited.
Objective: To enhance understanding of the clinical characteristics of different infection site mucormycosis and identify the factors associated with adverse outcomes.
Indian J Community Med
February 2025
Department of Community Medicine, Dr. V.M. Government Medical College, Solapur, Maharashtra, India.
Background: Mucormycosis, caused by filamentous fungi, is a rare but potentially fatal fungal infection associated with high morbidity and mortality. The COVID-19 pandemic has brought renewed attention to this infection, with an increasing number of cases worldwide. To study the clinico-demographic characteristics and their association with outcomes in mucormycosis cases.
View Article and Find Full Text PDF